Strigolactone-based biofertilizer for enhanced crop quality
A novel biofertilizer leveraging microbial cell factories to produce natural strigolactones, enhancing crop vigor, nutrient uptake, and productivity. This sustainable solution mimics natural soil dynamics and offers a promising alternative to synthetic fertilizers.
Overview
The strigolactone-based biofertilizer represents a groundbreaking solution in agricultural biotechnology, aiming to enhance crop quality through the use of microbial cell factories engineered to produce natural strigolactones. Unlike traditional methods that rely on synthetic analogs like GR24, this approach utilizes living systems to deliver a continuous, controlled release of diverse strigolactones. This innovation promises to improve crop vigor, nutrient uptake, and overall productivity, offering a sustainable alternative to synthetic fertilizers.
Technical specifications
- Microbial Cell Factories: Engineered to produce a range of natural strigolactones directly in situ.
- Encapsulation Technology: Ensures stability and controlled release of active molecules when applied to soil or seeds.
- Application: Direct application to crops for a more natural, sustained interaction with plant roots.
- Evaluation Metrics: Includes growth monitoring, nutrient uptake analysis, and metabolomic profiling to assess improvements in produce quality.
Technology readiness level
The technology is currently at TRL 4, having completed lab-scale optimization of microbial production and encapsulation. Greenhouse trials are underway for staple crops, fruits, and vegetables, with field trials planned to validate scalability and adaptability in real-world conditions.
About University of California, San Diego
UC San Diego is a comprehensive public research university in La Jolla, anchored by an integrated academic health system. On the east campus, the 23‑acre Science Research Park co‑locates corporate R&D with university programs and connects to the health sciences district, enabling daily interaction among scientists, clinicians, and companies. The Jacobs School’s Corporate Affiliates Program provides structured engagement and recruiting, while the Office of Innovation & Commercialization supports IP, licensing, and startup formation. The research enterprise is sustained by competitive federal funding, with recent awards exceeding $1.7B annually. Established commercialization pathways streamline sponsored research and help partners move from proof of concept to deployment.
delivered to your inbox.